Sign in
WithdrawnNo phase

Network-based Neurofeedback in PTSD

Key facts

Who runs it
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Where
Canada1 site in 1 countryChoose a country to see its sites
Trial code
Status
Withdrawn
Started
1 Oct 2023
Ended
Sept 2024
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Connectivity-based neurofeedback
Record updated
21 September 2023
Why it stopped
Study is no longer being conducted by Dr. Lanius - the principal investigator has been changed from Dr. Ruth Lanius to Dr. Andrew Nicholson.

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Can take part
Show the full registry criteria (19)Hide the full registry criteria

Who can take part

  • PTSD Group:
  • English speaking
  • age: 18-65
  • meets diagnostic criteria for PTSD (as determined by study assessment); Control Group:
  • English speaking
  • age: 18-65

Who cannot take part

  • extensive current use of narcotic medications; Control Group:
  • extensive current or past use of psychotropic or narcotic medications
  • Individuals with any implants, conditions, etc. that do not comply with 3-Tesla fMRI research safety standards (e.g., certain implants, pregnancy)
  • history of neurological disorder
  • history of any pervasive developmental disorder
  • history of significant head injury/lengthy loss of consciousness (e.g., a Glasgow Coma Scale Score < 15 at the time of incident assessed retrospectively by participant)
  • significant untreated medical illness
  • history of bipolar disorder
  • history of psychosis
  • any current or past mental health disorders
  • All participants:
  • alcohol/substance abuse or dependence within the last 3 months; PTSD Group:
  • extensive current or past psychotherapy

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This project will examine the use of real-time fMRI (rt-fMRI) neurofeedback in the regulation of neural networks underlying symptoms experienced by individuals with posttraumatic stress disorder (PTSD). Investigators will use rt-fMRI neurofeedback in order to facilitate emotion regulation during symptom induction, and examine individual differences that influence regulation capacities.

The 2 groups in the trial

  • Experimental neurofeedback armTreatment being tested

    The experimental arm will be able to view a feedback display that informs them of the strength of connectivity between the target regions. In both arms, feedback signals will be relayed back to the participant in the scanner through visualization software as a thermometer that increases or decreases as the extent to which the neural target model dominates (in other words, as the strength of directed connectivity between regions increases).

    Treatment: Connectivity-based neurofeedback

  • Sham-control neurofeedback armSham treatment, for comparison

    Participants in the sham-control arm will receive yoked sham neurofeedback signal (or fake signal), corresponding to a replayed feedback signal from a successful participant in the experimental group in order to ensure similar motivational states and following standard methods.

    Treatment: Connectivity-based neurofeedback

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Mechanisms of Network-based Real-time fMRI Neurofeedback in Patients With Posttraumatic Stress Disorder
Record updated
21 September 2023